PAIGE FAIRHEAD: Open Payments
NPI 1013446004 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 20 payments from 10 companies in 2025. Trend: 2023 $502 · 2024 $672 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $166 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $42 |
| CooperSurgical, Inc. | 2 | $41 |
| Organon LLC | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Octapharma USA, Inc. | 1 | $29 |
| Exeltis, USA Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $15 |
| Smith+Nephew, Inc. | 1 | $14 |
Products named: Veozah, Paragard T 380A, NEXPLANON, MYFEMBREE, FIBRYGA, SLYND, NOVASURE, PICO.
Industry payments across NE — which companies pay providers there.
